Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis LM. Leptomeningeal metastases in the MRI era. Neurology. 2010;74(18):1449–54. https://doi.org/10.1212/WNL.0b013e3181dc1a69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sener U, Kumthekar P, Boire A. Advances in the diagnosis, evaluation, and management of leptomeningeal disease. Neurooncol Adv. 2021;3(Suppl 5):v86–95. https://doi.org/10.1093/noajnl/vdab108.

Article  PubMed  PubMed Central  Google Scholar 

Le Rhun E, Devos P, Weller J, Seystahl K, Mo F, Compter A, Berghoff AS, Jongen JLM, Wolpert F, Ruda R, Brandsma D, van den Bent M, Preusser M, Herrlinger U, Weller M. Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors. Neuro Oncol. 2021;23(7):1100–12. https://doi.org/10.1093/neuonc/noaa298.

Article  PubMed  Google Scholar 

Pan Z, Yang G, He H, Yuan T, Wang Y, Li Y, Shi W, Gao P, Dong L, Zhao G. Leptomeningeal metastasis from solid tumors: clinical features and its diagnostic implication. Sci Rep. 2018;8(1):10445. https://doi.org/10.1038/s41598-018-28662-w.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lamba N, Cagney DN, Catalano PJ, Elhalawani H, Haas-Kogan DA, Wen PY, Wagle N, Lin NU, Aizer AA, Tanguturi S. Incidence proportion and prognosis of leptomeningeal disease among patients with breast vs. non-breast primaries. Neuro Oncol. 2023;25(5):973–83. https://doi.org/10.1093/neuonc/noac249.

Article  CAS  PubMed  Google Scholar 

Lamba N, Wen PY, Aizer AA. Epidemiology of brain metastases and leptomeningeal disease. Neuro Oncol. 2021;23(9):1447–56. https://doi.org/10.1093/neuonc/noab101.

Article  PubMed  PubMed Central  Google Scholar 

Abouharb S, Ensor J, Loghin ME, Katz R, Moulder SL, Esteva FJ, Smith B, Valero V, Hortobagyi GN, Melhem-Bertrandt A. Leptomeningeal disease and breast cancer: the importance of tumor subtype. Breast Cancer Res Treat. 2014;146(3):477–86. https://doi.org/10.1007/s10549-014-3054-z.

Article  CAS  PubMed  Google Scholar 

Lee SJ, Lee JI, Nam DH, Ahn YC, Han JH, Sun JM, Ahn JS, Park K, Ahn MJ. Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors. J Thorac Oncol. 2013;8(2):185–91. https://doi.org/10.1097/JTO.0b013e3182773f21.

Article  PubMed  Google Scholar 

Wilcox JA, Li MJ, Boire AA. Leptomeningeal Metastases: New Opportunities in the Modern Era. Neurotherapeutics. 2022;19(6):1782–98. https://doi.org/10.1007/s13311-022-01261-4.

Article  PubMed  PubMed Central  Google Scholar 

Yao H, Price TT, Cantelli G, Ngo B, Warner MJ, Olivere L, Ridge SM, Jablonski EM, Therrien J, Tannheimer S, McCall CM, Chenn A, Sipkins DA. Leukaemia hijacks a neural mechanism to invade the central nervous system. Nature. 2018;560(7716):55–60. https://doi.org/10.1038/s41586-018-0342-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boire A, Zou Y, Shieh J, Macalinao DG, Pentsova E, Massague J. Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis. Cell. 2017;168(6):1101–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Remsik J, Chi Y, Tong X, Sener U, Derderian C, Park A, Saadeh F, Bale T, Boire A. Leptomeningeal metastatic cells adopt two phenotypic states. Cancer Rep (Hoboken). 2022;5(4):e1236. https://doi.org/10.1002/cnr2.1236.

Article  CAS  PubMed  Google Scholar 

Chi Y, Remsik J, Kiseliovas V, Derderian C, Sener U, Alghader M, Saadeh F, Nikishina K, Bale T, Iacobuzio-Donahue C, Thomas T, Pe’er D, Mazutis L, Boire A. Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis. Science. 2020;369(6501):276–82. https://doi.org/10.1126/science.aaz2193.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wilcox J, Modelevsky LR, Thomas T, Cremers S, Young RJ, Reiner AS, Panageas K, Yu HA, Boire AA (2022) A phase Ia/Ib study of intrathecal deferoxamine in patients with leptomeningeal metastases. Journal of Clinical Oncology 40 (16_suppl):TPS2074-TPS2074. https://doi.org/10.1200/JCO.2022.40.16_suppl.TPS2074

Freilich RJ, Krol G, DeAngelis LM. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol. 1995;38(1):51–7. https://doi.org/10.1002/ana.410380111.

Article  CAS  PubMed  Google Scholar 

Chamberlain M, Junck L, Brandsma D, Soffietti R, Ruda R, Raizer J, Boogerd W, Taillibert S, Groves MD, Le Rhun E, Walker J, van den Bent M, Wen PY, Jaeckle KA. Leptomeningeal metastases: a RANO proposal for response criteria. Neuro Oncol. 2017;19(4):484–92. https://doi.org/10.1093/neuonc/now183.

Article  PubMed  Google Scholar 

Chukwueke UN, Wen PY (2019) Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice. CNS Oncol 8 (1):CNS28. https://doi.org/10.2217/cns-2018-0007

Le Rhun E, Devos P, Winklhofer S, Lmalem H, Brandsma D, Kumthekar P, Castellano A, Compter A, Dhermain F, Franceschi E, Forsyth P, Furtner J, Galldiks N, Gallego Perez-Larraya J, Gempt J, Hattingen E, Hempel JM, Lukacova S, Minniti G, O’Brien B, Postma TJ, Roth P, Ruda R, Schaefer N, Schmidt NO, Snijders TJ, Thust S, van den Bent M, van der Hoorn A, Vogin G, Smits M, Tonn JC, Jaeckle KA, Preusser M, Glantz M, Wen PY, Bendszus M, Weller M. Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort. Neuro Oncol. 2022;24(10):1726–35. https://doi.org/10.1093/neuonc/noac043.

Article  PubMed  PubMed Central  Google Scholar 

Le Rhun E, Weller M, Brandsma D, Van den Bent M, De Azambuja E, Henriksson R, Boulanger T, Peters S, Watts C, Wick W, Wesseling P. EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours. Annals of oncology. 2017 Jul 1;28:iv84-99. https://doi.org/10.1093/annonc/mdx221

E Rhun Le M Weller M Bent van den D Brandsma J Furtner R Ruda D Schadendorf J Seoane JC Tonn P Wesseling W Wick G Minniti S Peters G Curigliano M Preusser EG Committee clinicalguidelines@esmo.org EGCEa, 2023 Leptomeningeal metastasis from solid tumours: EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ESMO Open 8 5 101624https://doi.org/10.1016/j.esmoop.2023.101624

Nayar G, Ejikeme T, Chongsathidkiet P, Elsamadicy AA, Blackwell KL, Clarke JM, Lad SP, Fecci PE. Leptomeningeal disease: current diagnostic and therapeutic strategies. Oncotarget. 2017;8(42):73312–28. https://doi.org/10.18632/oncotarget.20272.

Article  PubMed  PubMed Central  Google Scholar 

Leal T, Chang JE, Mehta M, Robins HI. Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment. Curr Cancer Ther Rev. 2011;7(4):319–27. https://doi.org/10.2174/157339411797642597.

Article  PubMed  PubMed Central  Google Scholar 

Tu Q, Wu X, Le Rhun E, Blonski M, Wittwer B, Taillandier L, De Carvalho BM, Faure GC. Cell Search technology applied to the detection and quantification of tumor cells in CSF of patients with lung cancer leptomeningeal metastasis. Lung Cancer. 2015;90(2):352–7. https://doi.org/10.1016/j.lungcan.2015.09.008.

Article  PubMed  Google Scholar 

Le Rhun E, Massin F, Tu Q, Bonneterre J, Bittencourt Mde C, Faure GC. Development of a new method for identification and quantification in cerebrospinal fluid of malignant cells from breast carcinoma leptomeningeal metastasis. BMC Clin Pathol. 2012;12:21. https://doi.org/10.1186/1472-6890-12-21.

Article  PubMed  PubMed Central  Google Scholar 

van Bussel MTJ, Pluim D, Bol M, Beijnen JH, Schellens JHM, Brandsma D. EpCAM-based assays for epithelial tumor cell detection in cerebrospinal fluid. J Neurooncol. 2018;137(1):1–10. https://doi.org/10.1007/s11060-017-2691-6.

Article  CAS  PubMed  Google Scholar 

Le Rhun E, Tu Q, De Carvalho BM, Farre I, Mortier L, Cai H, Kohler C, Faure GC. Detection and quantification of CSF malignant cells by the Cell Search technology in patients with melanoma leptomeningeal metastasis. Med Oncol. 2013;30(2):538. https://doi.org/10.1007/s12032-013-0538-3.

Article  CAS  PubMed  Google Scholar 

Darlix A, Cayrefourcq L, Pouderoux S, Menjot de Champfleur N, Bievelez A, Jacot W, Leaha C, Thezenas S, Alix-Panabieres C. Detection of Circulating Tumor Cells in Cerebrospinal Fluid of Patients with Suspected Breast Cancer Leptomeningeal Metastases: A Prospective Study. Clin Chem. 2022;68(10):1311–22. https://doi.org/10.1093/clinchem/hvac127.

Article  PubMed  Google Scholar 

van Bussel MTJ, Pluim D, Milojkovic Kerklaan B, Bol M, Sikorska K, Linders DTC, van den Broek D, Beijnen JH, Schellens JHM, Brandsma D. Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases. Neurology. 2020;94(5):e521–8. https://doi.org/10.1212/WNL.0000000000008751.

Article  CAS  PubMed  Google Scholar 

Subira D, Simo M, Illan J, Serrano C, Castanon S, Gonzalo R, Granizo JJ, Martinez-Garcia M, Navarro M, Pardo J, Bruna J. Diagnostic and prognostic significance of flow cytometry immunophenotyping in patients with leptomeningeal carcinomatosis. Clin Exp Metastasis. 2015;32(4):383–91. https://doi.org/10.1007/s10585-015-9716-3.

Article  CAS